# Tianhui Chuangtou

> Tianhui Chuangtou is a VC fund in Beijing backing Biotechnology and Manufacturing. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 5
- Last investment: Aug 2022
- Lead investor: 20%
- Last updated: Aug 2026

Tianhui Chuangtou is an investment firm that provides asset management and investment consulting service.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Manufacturing | 2 | 40% |
| Recruiting | 1 | 20% |
| Outsourcing | 1 | 20% |
| Therapeutics | 1 | 20% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 40% |
| Angel | 1 | 20% |
| Series A | 1 | 20% |
| Series C | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Baiying Bio | Baiying Bio offers economic recombinant protein and antibody reagents and is a CRO vendor for life science researchers and biopharma companies. They provide services including HTP recombinant antibody and VHH production, bispecific antibody production, antibody humanization, VHH library generation, hybridoma sequencing, protein expression inmammalian cells, large-scale antibody production, and more. They delivered tens of thousands of recombinant antibodies to customers. | $72.6M | Series B | Aug 31, 2022 | https://www.biointron.com |
| Bohai New Enzyme | Bohai New Enzyme is a special enzyme research and development manufacturer. | $125M | Series C | Nov 05, 2021 | http://www.hzymes.com/ |
| Simcere Pharma | Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a researchand development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million. | $93.8M | Series B | Jun 04, 2021 | http://simcere.com |
| Novamab | Novamab focuses on the research and development of new nanobodies. The core members of the team have 15 years of experience in nanobody research and development, and are domestic nanobody "pioneers". At present, they have established an inhaled macromolecular drug research and development platform, an albumin nanobody long-acting platformand a nanobody double-antibody platform, etc., to give full play to nanobody The advantages of antibodies, the development of innovative nanobody drugs such as sprays and eye drops, to solve the pain points of clinical major chronic diseases in terms of administration methods, administration cycles, etc. | $15.4M | Series A | Mar 12, 2021 |  |
| Souqiantu.com | Souqiantu.com is an intelligent talent management service provider in China. | $425K | Angel | Jan 01, 2015 | https://www.souqiantu.com/ |

5 of 5 investments shown.

## Co-investors
- [ALAN AMC](https://shizune.co/investors/profile/alan-amc) — VC Fund, 1 deal together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 1 deal together
- [Binfu Capital](https://shizune.co/investors/profile/binfu-capital) — VC Fund, 1 deal together
- [CASH Capital](https://shizune.co/investors/profile/cash-capital) — VC Fund, 1 deal together
- [Chengshu Investment](https://shizune.co/investors/profile/chengshu-investment) — VC Fund, 1 deal together
- [CITIC Medical Fund](https://shizune.co/investors/profile/citic-medical-fund) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [Global Founders Capital](https://shizune.co/investors/profile/global-founders-capital) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Recruiting Investors in China](https://shizune.co/investors/recruiting-investors-china)
- [Recruiting VC Funds in China](https://shizune.co/investors/recruiting-vc-funds-china)

## FAQ

### What does Tianhui Chuangtou invest in?

Tianhui Chuangtou invests primarily in Biotechnology, Manufacturing and Recruiting startups, most often at Series B and Angel stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Tianhui Chuangtou last invest?

The most recent investment recorded for Tianhui Chuangtou closed in Aug 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co